The comparison of clinical features of minilaparoscopic radiofrequency myolysis with laparoscopic-assisted vaginal hysterectomy in the treatment of uterine myoma.
10.5468/kjog.2010.53.5.416
- Author:
Ji Hyun CHOI
1
;
Soo Ah KIM
;
Hyuk JUNG
Author Information
1. Department of Obstetrics and Gynecology, Chosun University School of Medicine, Gwangju, Korea. bimilo@hanmail.net
- Publication Type:Original Article
- Keywords:
Minilaparoscopic radiofrequency myolysis
- MeSH:
Female;
Gynecology;
Humans;
Hysterectomy, Vaginal;
Myoma;
Postoperative Complications;
Reoperation
- From:Korean Journal of Obstetrics and Gynecology
2010;53(5):416-421
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: To compare clinical features of minilaparoscopic radiofrequency myolysis (MLRFM) with laparoscopic-assisted vaginal hysterectomy (LAVH) in the treatment of uterine myoma. METHODS: Between 1st January 2006 and 31th March 2009, 125 patients underwent LAVH and 125 patients underwent MLRFM by same surgeon at the University of Chosun Hospital, Department of Gynecology. We compared the age of patients, indication for treatment, myoma size, major symptom, duration of procedure, amounts of blood loss and postoperative transfusion, length of hospital day, postoperative complication and satisfaction between the two groups. RESULTS: There were significant differences in duration of procedure between the LAVH group and the MLRFM group (69.0+/-31.6 minutes vs 43.5+/-19.8 minutes) and in the amounts of blood loss during procedure (215.2+/-215.0 mL vs 0.8+/-8.9 mL). The amounts of postoperative transfusion was 0.3+/-0.7 pints, 16 of the 125 (12.8%) for the LAVH group and no one underwent postoperative transfusion for the MLRFM group. There was significant difference in length of postoperative hospital day between the LAVH group and the MLRFM group (5.0+/-1.2 days vs 2.3+/-1.2 days). In the comparison of postoperative complications, there was no significant complication for the LAVH group, but there was major complications requiring readmission and reoperation for the MLRFM group. In MLRFM group, postoperative myoma size decreased compared to preoperative size. CONCLUSION: We conclude that there was no treatment of choice in uterine myoma. When considering treatment of uterine myoma, we should choose appropriate method after analyzing patient characteristics, general condition, uterine myoma characteristics case by case.
